TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.

Clare J Twist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.